N@N

Trung Huynh Initiated (ABBV) at Buy and Held Target at $170 on, Nov 18th, 2022

Trung Huynh of Credit Suisse, Initiated "AbbVie Inc." (ABBV) at Buy and Held Target at $170 on, Nov 18th, 2022.

Trung has made no other calls on ABBV in the last 4 months.

There are 12 other peers that have a rating on ABBV. Out of the 12 peers that are also analyzing ABBV, 5 agree with Trung's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
• Navin Jacob of "UBS" Maintained at Hold with Increased Target to $147 on, Monday, October 31st, 2022
• Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
• Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022
• Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $146 on, Monday, August 1st, 2022

These are the ratings of the 7 analyists that currently disagree with Trung

---

• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $178 on, Monday, October 31st, 2022
• Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $169 on, Monday, October 31st, 2022
• David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
• Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
• Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $155 on, Monday, August 1st, 2022
• Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, July 29th, 2022

Contributing Sources

---